Sunovion and Otsuka Initiate Clinical Development of Ulotaront for the Treatment of Generalized Anxiety Disorder
In full transparency, the following media release was submitted to SOURCE media through its business wire service. *** MARLBOROUGH – Sunovion Pharmaceuticals Inc. (Sunovion) and Otsuka Pharmaceutical Development & Commercialization,…